Assoc. Prof. Dr. Jiwen Cheng | Hepatology | Best Researcher Award

First Affiliated Hospital of Xi’an Jiaotong University | China.

Author Profile

🎓Education

Assoc. Prof. Dr. Jiwen Cheng earned his Ph.D. in Surgery from Xi’an Jiaotong University in 2017. He obtained his M.S. in Human Anatomy, Histology, and Embryology from Shanxi Medical University in 2011, following his B.S. in Clinical Medicine from the same institution in 2008

💼Professional Experience

Assoc. Prof. Dr. Jiwen Cheng currently serves as an Associate Professor at The First Affiliated Hospital of Xi’an Jiaotong University, a position he has held since 2020. Previously, he worked as a Research Associate at The Second Affiliated Hospital of Xi’an Jiaotong University from 2015 to 2019, where he contributed to groundbreaking research in pediatric oncology and molecular diagnostics.

📚Academic Cites

Dr. Jiwen Cheng has published extensively in high-impact journals, contributing valuable insights to the fields of pediatric oncology and molecular diagnostics. His research primarily focuses on molecular markers for cancer diagnosis and prognosis, as well as the association between genetic polymorphisms and the risk of pediatric tumors. His work has been widely cited, reflecting its significance in advancing medical research.

🧑‍🔬Technical Skills

Dr. Jiwen Cheng possesses expertise in molecular biology and genetic analysis, with a strong focus on pediatric oncology and hepatobiliary research. His technical proficiency extends to surgical techniques and clinical diagnostics, enabling him to contribute significantly to both research and medical practice.

📚Teaching Experience

As an instructor, Dr. Cheng teaches molecular diagnostics, pediatric surgery, and imaging techniques, providing in-depth knowledge to medical students and young researchers. He also serves as a mentor in clinical and translational medicine, guiding future professionals in cutting-edge medical research.

🏆Awards & Honors

Dr. Cheng has been recognized for his contributions to pediatric oncology and hepatobiliary research, securing prestigious grants, including the National Natural Science Foundation of China (NSFC) and funding from The Key R&D Program of Shaanxi Province. His leadership in groundbreaking studies has earned him recognition as a distinguished researcher in his field.

🔬Research Interests

Dr. Cheng’s research focuses on molecular markers for cancer diagnosis, prognosis, and targeted therapy, exploring the role of gene polymorphisms in pediatric solid tumors. His work also delves into the function of the vitamin D receptor in congenital biliary atresia and cholangitis, aiming to improve early diagnosis and treatment strategies.

📑Notable Publications

‘Vitamin D3/VDR alleviates double-stranded RNA virus-induced biliary epithelial cell damage by inhibiting autophagy’
Authors: N. Liu, P. Zhao, P. Cao, Y. Pan, J. Cheng
Year: 2025
Journal: BMC Gastroenterology

‘Application effect of non-stapled total laparoscopic Roux-en-Y anastomosis on radical resection of the congenital choledochal cyst’
Authors: J. Cheng, Q. Yu, J. Fu, Q. Gao, P. Li
Year: 2025
Journal: Chinese Journal of Pediatric Surgery

‘YTHDF3 rs7464 A > G polymorphism increases Chinese neuroblastoma risk: A multiple-center case–control study’
Authors: H. Lin, Y. Chen, L. Chen, Z. Zhuo, J. He
Year: 2025
Journal: IUBMB Life

‘LMO family gene polymorphisms and Wilms tumor susceptibility in Chinese children: A five-center case-control study’
Authors: W. Fu, L. Deng, X. Yan, J. He, G. Liu
Year: 2024
Journal: BMC Cancer

‘Transbronchoscopic injection of indocyanine green during thoracoscopic anatomical pulmonary segmentectomy in infants’
Authors: Y. Liu, X. Guo, Q. Yu, C. Miao, P. Li
Year: 2024
Journal: Chinese Journal of Pediatric Surgery